Johnson & Johnson Needs Time To Consolidate (Technical Analysis And Downgrade)
Johnson & Johnson's long-term prospects are promising due to strong drug pipeline developments and significant R&D ...
Hosted on MSN1mon
Johnson & Johnson (JNJ): One of the Best Vaccine Stocks to Buy According to Hedge Funds
We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the ...
AOL1mon
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study
Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The E.mbrace study is a ...
Yahoo Finance2d
Johnson & Johnson (NYSE:JNJ) Presents Promising Nipocalimab Data At AAN Annual Meeting
Johnson & Johnson experienced an 11% price increase over the last quarter. This movement coincided with several corporate developments, including the presentation of breakthrough research on ...
U.S. to end funding for child vaccines in developing countries, NY Times reports
The Trump administration intends to terminate the United States’ financial support for Gavi, the organization that has helped purchase critical ...